From chemical compounds to herbal interventions: a transfer learning-based perturbational transcriptome prediction

Qingyuan Liu1, Boyang Wang1, Shao Li1

  • 1Institute for TCM-X, Department of Automation, Tsinghua University, Beijing 100084, China.

Abstract

Insights

This study developed a predictive framework using transfer learning to forecast herbal medicine

Area of Science:

  • Computational biology
  • Pharmacology
  • Genomics

Background:

  • Transcriptomic profiles are crucial for cancer drug discovery and mechanism of action (MOA) analysis.
  • Traditional Chinese Medicine (TCM) has anticancer potential but faces challenges due to its complexity and limited transcriptomic data.
  • A data gap exists for herbal interventions compared to chemical compounds, hindering TCM research.

Purpose of the Study:

  • To establish a predictive computational framework for herbal transcriptomic responses in tumor cell models.
  • To address the data bottleneck in transcriptome-based anticancer TCM research.
  • To enable scalable and cost-effective in silico screening of anticancer herbs.

Main Methods:

  • Developed a transfer learning-based encoder-decoder prediction framework with self-attention.
  • Pre-trained the model on large-scale compound perturbation datasets.
  • Fine-tuned the model with limited transcriptomic data from 11 herbs across 4 tumor cell lines.

Main Results:

  • Achieved strong predictive performance with high R2 (0.8561) and Pearson correlation (0.9258).
  • Demonstrated robust generalization to new herbal interventions.
  • Showcased significant improvements in prediction accuracy and stability under data-limited conditions due to transfer learning.

Conclusions:

  • The developed framework offers a scalable and cost-effective computational approach for anticancer herbal in silico screening.
  • Facilitates preliminary mechanism of action (MOA) exploration for herbal medicines.
  • Supports synergistic pattern analysis for multi-herb prescriptions in cancer drug discovery.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...